World’s first study of digital follow-up of patients treated with immune-checkpoint inhibitors uses Kaiku Health.
Debiopharm International working with Kaiku Health for digital patient monitoring in prostate cancer
Debiopharm Innovation Fund’s portfolio company BC Platforms to create a Health Data Discovery Platform for the UK’s National Biobank Network
Welcome to our new website
Increased Overall Survival (OS) of patients with pancreatic cancer: results of a Phase III study of adjuvant mFOLFIRINOX presented at…
Information letter – Yakult, our partner in Japan, announced the approval of Elplat in Gastric Cancer
Biocartis Successful IPO – The Start of a New Era